Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001330411 | SCV001522085 | uncertain significance | Warburg micro syndrome 1 | 2020-06-26 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Genetic Services Laboratory, |
RCV001820023 | SCV002066181 | uncertain significance | not specified | 2017-09-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002546390 | SCV003255681 | uncertain significance | not provided | 2022-04-24 | criteria provided, single submitter | clinical testing | This sequence change replaces lysine, which is basic and polar, with arginine, which is basic and polar, at codon 459 of the RAB3GAP1 protein (p.Lys459Arg). This variant is present in population databases (rs772002275, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with RAB3GAP1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1029183). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |